Related Experiment Videos
The role of genomics in patients with advanced prostate cancer
1Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
Clinical Advances in Hematology & Oncology : H&O
|October 18, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer.
bioRxiv : the preprint server for biology·2026
Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.
Clinical advances in hematology & oncology : H&O·2026
Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and future.
Clinical advances in hematology & oncology : H&O·2026
Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clinical advances in hematology & oncology : H&O·2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026
From genomic instability to epigenetic regulation: the role of DNA repair gene variants and non-coding RNAs in colorectal carcinogenesis.
Nucleosides, nucleotides & nucleic acids·2026
Insights into Shared Genetic Architecture Linking Thyroid Function and Cancer.
Endocrine-related cancer·2026
Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance.
Cancer heterogeneity and plasticity·2026